Exploring Key Insights of the Circulating Tumor Cells Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the circulating tumor cells market grown over the years?
In recent times, the market size for circulating tumor cells has seen phenomenal growth. Projected growth from $11.9 billion in 2024 to $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%, indicates a booming market. The historic growth has been driven by factors such as the prevalence and incidence of cancer, the usefulness of these cells in cancer staging, the introduction of liquid biopsy, patient preference for less invasive tests, regulatory backing for liquid biopsies, and an emphasis on early detection of cancer.
What Is the forecasted market size and growth rate for the circulating tumor cells market?
The market size of circulating tumor cells is predicted to undergo swift expansion in the forthcoming years, with estimates suggesting a growth to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth during the forecast period can be linked to factors such as the uptake of point-of-care CTC testing, the use of microfluidics, attention to unique cancer forms, standardization of CTC tests, development of CTC-centric clinical trials, as well as financial growth and expansion in emerging markets. Key trends for the forecast period feature developments in CTC extraction methods, state funding for CTC research, improvements in CTC detection technology, the utilization of liquid biopsy for cancer surveillance, integration with single-cell analysis, and technological fusion with artificial intelligence (AI).
Get your circulating tumor cells market report here!
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
What are the major factors driving growth in the circulating tumor cells market?
The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is characterized by the uncontrolled proliferation of a few cells within the body, which metastasize to different parts. Circulating tumor cells aid in early cancer detection and diagnosis, thereby, their demand increases parallelly with the surge in cancer incidence. For example, the American Cancer Society Journals, an American voluntary health entity, estimated in January 2023 that the US would have 1,958,310 new cancer diagnoses and about 609,820 cancer-related deaths. Consequently, the escalating prevalence of cancer is propelling the expansion of the circulating tumor cells market.
What key areas define the segmentation of the global circulating tumor cells Market?
The circulating tumor cells market covered in this report is segmented –
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp
What are the top market players propelling the growth of the circulating tumor cells industry?
Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.
What are the key trends shaping the future of the circulating tumor cells market?
One of the prominent trends making waves in the circulating tumor cells market is product innovation. Leading companies in this market are intent on creating novel products to solidify their market standing. A case in point is Bio-Rad Laboratories, Inc., a medical laboratory based in the US, which rolled out the Celselect Slides 2.0 in June 2024. This product has been developed to boost the capture of scarce cells and circulating tumor cells (CTCs), thereby enhancing the precision and productivity of cell analysis for clinical and research purposes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950
What regions are dominating the circulating tumor cells market growth?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Surgery Devices And Equipment Global Market Report 2024
Electrosurgical Devices And Equipment Global Market Report 2024
Robotic Surgery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/robotic-surgery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
